omeprazole has been researched along with aspirin in 169 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (6.51) | 18.7374 |
| 1990's | 18 (10.65) | 18.2507 |
| 2000's | 62 (36.69) | 29.6817 |
| 2010's | 68 (40.24) | 24.3611 |
| 2020's | 10 (5.92) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bergmann, JF; Caulin, C; Chassany, O; Lemaire, M; Segrestaa, JM; Simoneau, G | 1 |
| Koop, H | 1 |
| Bright, RM; DeNovo, RC; Jenkins, CC; Patton, CS; Rohrbach, BW | 1 |
| Bhaskar, NK; Daneshmend, TK; Hawkey, CJ; Stein, AG | 1 |
| Niida, H; Nishiwaki, H; Okabe, S; Takeuchi, K | 1 |
| Okabe, S | 1 |
| Hara, K; Higaki, E; Higuchi, T; Okabe, S; Sato, M | 1 |
| Bigard, MA | 1 |
| Dammann, HG; Müller, P; Simon, B | 2 |
| Gilbertson, SK; Kolbasa, KP; Lancaster, C; Olafsson, AS; Robert, A | 1 |
| Jourdan, MH; Mason, RC; Rowe, PH | 1 |
| Carter, DC; Salim, AS; Utley, RJ | 1 |
| Brzozowski, T; Konturek, SJ; Radecki, T | 1 |
| Andersson, K; Larsson, H; Mattsson, H | 1 |
| Okabe, S; Okada, Y; Yamamoto, O | 1 |
| Elsner, H; Müller, P; Simon, B | 1 |
| Kamishiro, T; Kawaguchi, K; Masuda, M; Matsukura, H; Uchida, A | 1 |
| Behler, EM; Elta, GH; Loeffler, KM; Scheiman, JM | 1 |
| Diwan, PV; Krishna, DR; Sastry, MS | 1 |
| Coffey, RJ; Greenson, JK; Meise, KS; Scheiman, JM | 1 |
| Fuchs, W; Müller, P; Simon, B | 1 |
| Dial, EJ; Felder, TB; Giraud, MN; Illich, PA; Lichtenberger, LM; Sanduja, SK | 1 |
| Endo, T; Nagasaki, M; Noto, T; Yomota, E | 1 |
| Müller, P; Simon, B | 1 |
| Ayanoglu-Dülger, G; Imeryüz, N; Nefesoglu, FZ; Ulusoy, NB | 1 |
| Akiba, Y; Kaunitz, JD; Tanaka, S | 1 |
| Bertaccini, G; Coppelli, G; Coruzzi, G; Frati, P | 1 |
| Harewood, G | 1 |
| Cornudella, R; Esteva, F; Iñarrea, P; Lanas, A | 1 |
| Fujita, A; Takeuchi, K; Tashima, K; Umeda, M | 1 |
| Denaro, MG; Faggio, C; Lionetto, MG; Trischitta, F | 1 |
| Cheon, HG; Lee, DH; Lee, SS; Lim, H | 1 |
| Lanas, AI | 1 |
| Chan, FK; Chan, HL; Chung, SC; Hui, Y; Lai, MS; Lau, JY; Lee, YT; Leung, VK; Leung, WK; Suen, BY; Sung, JJ; Wu, JC | 1 |
| Arbak, S; Ayanoğlu-Dülger, G; Hürdağ, C; Paskaloğlu, K; Sener-Muratoğlu, G | 1 |
| Boknik, P; Domschke, W; Fischer, H; Huber, V; Konturek, JW; Luess, H; Neumann, J; Schmitz, W | 1 |
| Jacobson, BC | 1 |
| McCarthy, DM | 1 |
| Astudillo, L; Bustamante, C; Rodríguez, JA; Schmeda-Hirschmann, G | 1 |
| Di Stasi, LC; Gonzalez, FG | 1 |
| Astudillo, L; Rodriguez, JA; Schmeda-Hirschmann, G | 1 |
| Chan, AO; Chu, KM; Hu, WH; Hui, WM; Lai, CL; Lai, KC; Lam, SK; Lau, GK; Wong, BC; Wong, J; Wong, WM; Yuen, MF | 1 |
| Fernández-Fernández, FJ | 1 |
| Harris, AW; Maiden, LP | 1 |
| Guda, N; Vakil, N | 1 |
| Wepner, U | 1 |
| Nelson, DB; Sawhney, MS | 1 |
| Jansen, JB; Laheij, RJ; Van Rossum, LG; Verheugt, FW | 1 |
| Bajador, E; Cabrol, J; Cucala, M; Gomollón, F; Lanas, A; Lorente, S; Márquez, JL; Montoro, M; Nuevo, J; Pérez-Roldan, F; Quintero, E; Rodrigo, L; Santolaria, S | 1 |
| Ferrández, A; Lanas, A | 1 |
| Füessl, HS | 1 |
| Laine, L | 1 |
| Chang, CM; Chen, WH; Ng, FH; Wong, BC; Wong, SY | 1 |
| Jankowski, J; Moayyedi, P | 1 |
| Singh, G | 1 |
| Celikel, CA; Giral, A; Kalayci, C; Ozdogan, O; Tozun, N; Ulusoy, NB | 1 |
| Kotaira, J | 1 |
| Cryer, B | 2 |
| D'Ambrosio, LP; Franceschi, M; Leandro, G; Longoa, MG; Orsitto, G; Perri, FC; Pilotto, A; Scarcelli, C | 1 |
| Amer, F; Christopoulos, NG; Goldstein, JL; Huang, B | 1 |
| Arkkila, PE; Färkkilä, M; Kosunen, TU; Mäkinen, J; Rautelin, H; Seppälä, K; Sipponen, P | 1 |
| Chiou, CF; Ofman, JJ; Spiegel, BM | 1 |
| Cho, YK; Jeon, WK; Keum, DK; Kim, BI; Kim, HJ; Kim, SH; Park, DI; Park, SH; Sohn, CI; Sung, IK | 1 |
| Dharmani, P; Maurya, R; Mishra, PK; Palit, G; Singh Chauhan, V | 1 |
| Chauhan, VS; Dharmani, P; Maurya, R; Mishra, PK; Palit, G | 1 |
| Hull, R; Marshall, RW; Marshall, VJ | 1 |
| Agustí-Escasany, A; Vallano-Ferraz, A | 1 |
| Go, MF | 1 |
| Hu, FL; Ji, KY | 1 |
| Abgrall, JF; Arnaud, B; Boschat, J; Gilard, M; Le Gal, G | 1 |
| Gopalakrishnan, G; Kavimani, S; Malairajan, P; Narasimhan, S; Veni, KJ | 1 |
| Bayan, K; Canoruç, F; Daniş, R; Dursun, M; Ertem, M; Kilinç, N; Tüzün, Y; Yilmaz, S | 1 |
| Arnesen, Ø; Riis, JS | 1 |
| Huntoon, MA; Watson, JC | 1 |
| Matsuda, H; Nagatomo, A; Ochi, M; Yoshikawa, M | 1 |
| Dregelid, E | 1 |
| Díte, P; Kunovská, M; Münzová, H; Novotný, I | 1 |
| Bobb, A; Bulsiewicz, W; Christensen, K; Coté, GA; Howden, CW; Norvell, JP; Postelnick, M; Rice, JP | 1 |
| Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
| Goto, S; Serebruany, V | 1 |
| Braun, S; Hadamitzky, M; Kastrati, A; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Vogt, W; von Beckerath, N | 1 |
| Attwood, S; Barr, H; deCaestecker, J; Jankowski, J | 1 |
| Bretagne, JF | 1 |
| Herszényi, L; Juhász, M; Tulassay, Z | 1 |
| Börgel, J; Endres, HG; Engelhardt, A; Krüger, JC; Lask, S; Mügge, A; Neubauer, H | 1 |
| Nathisuwan, S; Panomvana, D; Sansanayudh, N; Siriswangvat, S | 1 |
| Morini, S; Zullo, A | 1 |
| Bhatt, DL; Cannon, CP; Cohen, M; Contant, CF; Cryer, BL; Goldsmith, MA; Laine, L; Lanas, A; Lapuerta, P; Murphy, SA; Schnitzer, TJ; Scirica, BM; Shook, TL | 1 |
| Grad, Y; Ross, JJ; Schaffer, AC | 1 |
| Kandulski, A; Malfertheiner, P; Venerito, M | 1 |
| Cai, J; Fan, L; Liu, CF; Sun, J; Wang, ZG; Wu, Q | 1 |
| Grad, YH; Levy, BD; Loscalzo, J; Seifter, JL | 1 |
| Danikiewicz, A; Hudzik, B; Lekston, A; Polonski, L; Romanowski, W; Szkodzinski, J; Wilczek, K; Zubelewicz-Szkodzinska, B | 1 |
| Jobe, BA; Lombard, CM; Triadafilopoulos, G | 1 |
| Lanas, A; Sostres, C | 1 |
| Vassiliou, V | 1 |
| Dev, K; Maurya, R; Palit, G; Sahai, M; Sharma, R; Singh, N; Yadav, DK | 1 |
| Hiraishi, H; Kanke, K; Maeda, M; Sasai, T; Shimada, T | 1 |
| Chen, JS; Chen, L; Chen, YD; Guo, YS; Huang, TT; Liu, HB; Ren, YH; Sun, ZJ; Wang, CY; Wang, Y; Xie, YJ; Zhao, M | 1 |
| Abe, Y; Endo, H; Higurashi, T; Hosono, K; Iida, H; Inamori, M; Koide, T; Nakajima, A; Sakai, E; Sakamoto, Y; Sekino, Y; Takahashi, H; Tokoro, C; Yoneda, M | 1 |
| Yeomans, ND | 1 |
| Chen, PF; Hsiao, FY; Huang, WF; Mullins, CD; Tsai, YW; Wen, YW | 1 |
| Antonino, M; Bliden, KP; Fort, J; Gesheff, M; Gurbel, PA; Plachetka, JR; Tantry, US; Zhang, Y | 1 |
| Harrison, RW; Mahaffey, KW | 1 |
| Abe, T; Fujioka, T; Inoue, K; Kodama, M; Mizukami, K; Murakami, K; Okimoto, T; Uchida, M | 1 |
| Abdelwahab, SI; Abdulla, MA; Ali, HM; Hadi, AH; Salga, MS; Taha, MM | 1 |
| Hashimoto, E; Izuhara, C; Kaneko, S; Takayama, S; Takeuchi, K; Yamada, N; Yamanaka, S | 1 |
| Horiuchi, H; Ikeda, T; Imai, M; Jinnai, T; Kato, Y; Kimura, T; Makiyama, T; Shirakawa, R; Tada, T; Tazaki, J; Yamane, K | 1 |
| Blackler, R; Bolla, M; Ongini, E; Syer, S; Wallace, JL | 1 |
| Geetha, A; Megala, J | 1 |
| Endo, T; Fukui, K; Hibi, K; Himeno, H; Kimura, K; Morita, S; Sugano, T; Tsukahara, K; Umemura, S; Yano, H | 1 |
| Abd-Elmageid, SA; Alshailabi, EM; El-Shinnawy, NA | 1 |
| Inadomi, JM | 1 |
| Horiuchi, H | 1 |
| Chen, YF; Dang, DS; Liu, Q; Shi, GB; Yan, M; Zhao, QC | 1 |
| Antonino, M; Bliden, KP; Chai, S; Fort, JG; Gesheff, M; Gesheff, T; Gurbel, PA; Jeong, YH; Shuldiner, A; Tantry, US; Zhang, Y | 1 |
| Agrawal, M; Madhur, G; Mishra, V; Narender, T; Onasanwo, SA; Palit, G; Pandey, HP; Rastogi, P | 1 |
| Cutfield, NI; Tong, DC | 1 |
| Brickl, R; Ehrlich, J; Eisert, W; Offman, E; Schobelock, MJ; VanderMaelen, CP | 1 |
| Abramowitz, Y; Arbel, Y; Banai, S; Berliner, S; Birati, EY; Deutsch, V; Finkelstein, A; Halkin, A; Herz, I; Keren, G; Kletzel, H | 1 |
| Fort, JG; Miner, PB; Zhang, Y | 1 |
| Barthwal, MK; Khaliq, T; Mishra, V; Narender, T; Palit, G; Pandey, HP; Singh, VK; Tiwari, S | 1 |
| Labenz, J | 1 |
| Bliden, KP; Brener, M; Franzese, CJ; Gesheff, MG; Gurbel, PA; Tabrizchi, A; Tantry, U | 1 |
| Chen, G; Du, Y; Hang, L; Ma, B | 1 |
| Andersson, T; Galbraith, H; Nagy, P; Niazi, M; Nylander, S; Ranjan, S; Wallentin, L | 1 |
| Cryer, BL; Eisen, GM; Fort, JG; Goldstein, JL; Lanas, A; Miller, AB; O'Connor, C; Scheiman, JM; Whellan, DJ; Zhang, Y | 1 |
| Chan, HH; Chen, WC; Cheng, JS; Chiang, PH; Lai, KH; Li, YD; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, EM | 1 |
| Bhatt, DL; Cannon, CP; Cohen, M; Cryer, BL; Doros, G; Goldsmith, MA; Laine, L; Lanas, A; Lapuerta, P; Liu, Y; McIntosh, AI; Schnitzer, TJ; Vardi, M | 1 |
| Ali, A; Aslam, B; Javed, I; Khaliq, T; Majeed, W; Muhammad, F; Raza, A | 1 |
| Cryer, BL; Eisen, GM; Fort, JG; Goldstein, JL; Lanas, A; Scheiman, JM; Whellan, DJ | 1 |
| Mitrov-Winkelmolen, L; Overdiek, HWPM; Swank, DJ; Touw, DJ; van Buul-Gast, MW; van Schaik, RHN | 1 |
| Fort, JG; Goldstein, JL; Scheiman, JM; Whellan, DJ | 1 |
| Bhatt, DL; Cannon, CP; Cohen, M; Cryer, BL; Doros, G; Goldsmith, MA; Hsieh, WH; Laine, L; Lanas, A; Lapuerta, P; Liu, Y; Schnitzer, TJ; Shook, TL; Vaduganathan, M | 2 |
| Farkouh, ME | 1 |
| Bliden, K; Chaudhary, R; Gurbel, PA; Sharma, T; Tantry, U | 1 |
| Fort, JG; Han, Y; Schofield, D; Tursi, JP; Zhang, W | 1 |
| García-Rayado, G; Lanas, A; Sostres, C | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
| Haseeb, S; Kagolanu, D; Lam, P; Munnangi, S; Sayedy, N; Shah, S; Stephenson, K; Viswanathan, P | 1 |
| Patel, AD; Patel, VB; Shah, DA | 1 |
| Bravo-Gutiérrez, A; García-Romera, Á; González-Delgado, C; González-Hernández, S; Soto-Darias, I | 1 |
| Abdelaleem, EA; Abdelhamid, NS; Abou El Ella, DA; Mahmoud, AM | 1 |
| Chen, WC; Cheng, JS; Chuah, SK; Hsu, PI; Kao, SS; Peng, NJ; Shie, CB; Tang, SY; Tsai, KF; Tsay, FW; Tseng, ZF | 1 |
| Ghasemkhani, N; Namazi, F; Nazifi, S; Tabrizi, AS | 1 |
| Abdelazim, AH; Almrasy, AA; El-Olemy, A; Hasan, MA; Madkour, AW; Ramzy, S; Shahin, M | 1 |
| Badrawy, M; El-Mammli, MY; Elmasry, MS; Hassan, WS; Serag, A | 1 |
| Badrawy, M; El-Mammli, MY; Elmasry, MS; Hassan, WS | 1 |
| Affuso, F; Bellavite, P; Fazio, S; McCullough, PA; Pandolfi, S; Zanolin, E | 1 |
| Beloosesky, Y; Boltin, D; Gingold-Belfer, R; Issa, N; Koren-Morag, N; Meyerovitch, J; Peleg, N; Schmilovitz-Weiss, H; Sharon, E | 1 |
19 review(s) available for omeprazole and aspirin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Bucladesine; Dogs; Duodenal Ulcer; Ethanol; Gastric Juice; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Mice; Omeprazole; Parietal Cells, Gastric; Rats; Stomach Ulcer; Structure-Activity Relationship | 1986 |
Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Diseases; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Risk Factors; Sucralfate | 2001 |
Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic | 2002 |
The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dyspepsia; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2003 |
Understanding NSAID-PPI-COX-2 interrelationships.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimidazoles; Cyclooxygenase Inhibitors; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides | 2004 |
Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cost-Benefit Analysis; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Lactones; Lansoprazole; Naproxen; Omeprazole; Proton Pump Inhibitors; Pyrazoles; Rheumatology; Sulfonamides; Sulfones | 2005 |
Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dyspepsia; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Rheumatic Diseases; Risk Factors | 2006 |
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Lansoprazole; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2009 |
Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastroenterology; Gastrointestinal Hemorrhage; Humans; Myocardial Infarction; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Ticlopidine | 2010 |
[Dilemma between gastroprotection and cardiovascular prevention].
Topics: Alleles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Long-Term Care; Mutation; Omeprazole; Peptic Ulcer Hemorrhage; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Survival Analysis; Ticlopidine; Treatment Outcome | 2010 |
[Strategy to manage low dose aspirin-induced gastrointestinal injury].
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Famotidine; Gastric Mucosa; Humans; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Proton Pump Inhibitors; Ticlopidine | 2011 |
Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Drug Therapy, Combination; Esomeprazole; Humans; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk | 2011 |
Clopidogrel and PPI interaction: clinically relevant or not?
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Thienopyridines; Ticlopidine | 2012 |
PA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.
Topics: Administration, Oral; Aspirin; Biological Availability; Cardiovascular Diseases; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Tablets | 2013 |
Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.
Topics: Aspirin; Cardiovascular Diseases; Coronary Artery Disease; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Secondary Prevention | 2017 |
Yosprala - a combination of aspirin and omeprazole.
Topics: Animals; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Humans; Omeprazole | 2017 |
Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Secondary Prevention; Stomach Ulcer | 2017 |
Usefulness of PA32540 in Protecting the Gastric Layer While Providing Secondary Prevention for Coronary Artery Disease.
Topics: Administration, Oral; Aspirin; Coronary Artery Disease; Double-Blind Method; Drug Combinations; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention | 2017 |
49 trial(s) available for omeprazole and aspirin
| Article | Year |
|---|---|
Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Analysis of Variance; Anti-Ulcer Agents; Aspirin; Double-Blind Method; Female; Gastric Mucosa; Gastroscopy; Humans; Lansoprazole; Male; Membrane Potentials; Omeprazole; Reference Values; Stomach Ulcer | 1992 |
Abolition by omeprazole of aspirin induced gastric mucosal injury in man.
Topics: Adult; Aspirin; Double-Blind Method; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Male; Omeprazole; Randomized Controlled Trials as Topic | 1990 |
[Protective effect of omeprazole on gastric lesions induced by a single dose of aspirin in man].
Topics: Aspirin; Clinical Trials as Topic; Double-Blind Method; Gastric Mucosa; Humans; Male; Omeprazole | 1988 |
[Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Topics: Adult; Alprostadil; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Gastric Mucosa; Gastroscopy; Humans; Misoprostol; Omeprazole; Prostaglandins E; Prostaglandins, Synthetic; Random Allocation; Ranitidine; Rioprostil; Stomach Ulcer | 1986 |
[Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study].
Topics: Adult; Alprostadil; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Gastroscopy; Humans; Indomethacin; Misoprostol; Omeprazole; Prostaglandins E; Ranitidine; Rioprostil; Stomach Ulcer | 1987 |
[Protective effect of omeprazole against low-dose acetylsalicylic acid. Endoscopic controlled double-blind study in healthy subjects].
Topics: Adult; Aspirin; Double-Blind Method; Endoscopy, Gastrointestinal; Humans; Male; Omeprazole | 1995 |
Omeprazole ameliorates aspirin-induced gastroduodenal injury.
Topics: Adult; Aspirin; Double-Blind Method; Duodenum; Female; Gastric Mucosa; Humans; Male; Omeprazole; Peptic Ulcer | 1994 |
Transforming growth factor-alpha (TGF-alpha) levels in human proximal gastrointestinal epithelium. Effect of mucosal injury and acid inhibition.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy, Needle; Cimetidine; Duodenum; Gastric Acid; Gastric Mucosa; Humans; Intestinal Mucosa; Omeprazole; Peptic Ulcer; Pyloric Antrum; Radioimmunoassay; Transforming Growth Factor alpha | 1997 |
[Studies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Double-Blind Method; Duodenoscopy; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Ranitidine | 1997 |
[The action of the proton pump inhibitor pantoprazol against acetylsalicylic acid-induced gastroduodenopathy in comparison to ranitidine. An endoscopic controlled, double blind comparison].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1998 |
Interaction of omeprazole with enteric-coated salicylate tablets.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Area Under Curve; Aspirin; Biological Availability; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Omeprazole; Salicylates; Tablets, Enteric-Coated | 1998 |
Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man.
Topics: Adult; Anti-Ulcer Agents; Aspirin; Bleeding Time; Drug Interactions; Humans; Male; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Time Factors | 2000 |
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Naproxen; Omeprazole; Organometallic Compounds; Secondary Prevention; Tetracycline | 2001 |
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electrophoresis, Polyacrylamide Gel; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Isoenzymes; Lansoprazole; Membrane Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Prostaglandin-Endoperoxide Synthases | 2001 |
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Proton Pump Inhibitors; Recurrence; Statistics, Nonparametric | 2002 |
Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Heartburn; Humans; Male; Middle Aged; Nausea; Omeprazole; Pain; Proton Pump Inhibitors; Rabeprazole | 2003 |
Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk -- a single-blind, randomized controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Risk Factors; Single-Blind Method; Ticlopidine | 2004 |
Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Coronary Disease; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2004 |
[Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Misoprostol; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2004 |
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimidazoles; Dose-Response Relationship, Drug; Endoscopes, Gastrointestinal; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Sulfoxides | 2004 |
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Humans; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Ulcer; Treatment Outcome | 2004 |
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Recurrence; Stomach Ulcer; Treatment Outcome | 2005 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects | 2005 |
Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Comorbidity; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Recurrence | 2007 |
Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Regression Analysis; Stents; Ticlopidine | 2010 |
Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabeprazole; Ticlopidine; Treatment Outcome | 2010 |
Clopidogrel with or without omeprazole in coronary artery disease.
Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2010 |
[Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation; Postoperative Period; Proton Pump Inhibitors; Stents; Ticlopidine | 2010 |
Effect of omeprazole on the concentration of interleukin-6 and transforming growth factor-β1 in patients receiving dual antiplatelet therapy after percutaneous coronary intervention.
Topics: Aged; Anti-Ulcer Agents; Aspirin; Biomarkers; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Interleukin-6; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Predictive Value of Tests; Ticlopidine; Transforming Growth Factor beta1; Treatment Outcome | 2010 |
Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Ticlopidine | 2011 |
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Aspirin; Capsule Endoscopy; Drug Therapy, Combination; Female; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Lacticaseibacillus casei; Male; Middle Aged; Omeprazole; Pilot Projects; Probiotics; Prospective Studies; Treatment Outcome | 2011 |
Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study.
Topics: Adult; Anti-Ulcer Agents; Aspirin; Clopidogrel; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Humans; Least-Squares Analysis; Male; Omeprazole; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Ticlopidine | 2011 |
Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Capsule Endoscopy; Cross-Over Studies; Double-Blind Method; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Omeprazole; Placebos; Quinolones; Young Adult | 2011 |
Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.
Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Blood Platelets; Clopidogrel; Drug Antagonism; Famotidine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Omeprazole; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2012 |
The influence of omeprazole on platelet inhibition of clopidogrel in various CYP2C19 mutant alleles.
Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Aspirin; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Humans; Male; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Young Adult | 2012 |
Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Topics: Administration, Oral; Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studies; Gastrointestinal Diseases; Humans; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Ticlopidine; Treatment Outcome | 2013 |
Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
Topics: Adolescent; Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Cross-Over Studies; Dipyridamole; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Young Adult | 2013 |
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Aspirin; Chi-Square Distribution; Clopidogrel; Cross-Over Studies; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Famotidine; Female; Histamine H2 Antagonists; Humans; Israel; Linear Models; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Area Under Curve; Aspirin; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Tablets; Tablets, Enteric-Coated; Young Adult | 2013 |
Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
Topics: Angiography; Aspirin; Breath Tests; Carotid Arteries; Carotid Stenosis; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stents; Ticlopidine | 2013 |
Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Topics: Adolescent; Adult; Area Under Curve; Aspirin; Clopidogrel; Cross-Over Studies; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Healthy Volunteers; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Platelet Aggregation; Proton Pump Inhibitors; Ticlopidine; Young Adult | 2014 |
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Incidence; Omeprazole; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stomach Ulcer; Tablets, Enteric-Coated; United States | 2014 |
The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Young Adult | 2015 |
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.
Topics: Aged; Aspirin; Cardiovascular Diseases; Dosage Forms; Drug Combinations; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Treatment Outcome | 2016 |
The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.
Topics: Administration, Oral; Anti-Ulcer Agents; Area Under Curve; Aspirin; Female; Gastric Bypass; Humans; Male; Middle Aged; Obesity, Morbid; Omeprazole; Platelet Aggregation Inhibitors | 2016 |
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Topics: Adolescent; Adult; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Disease Progression; Double-Blind Method; Drug Combinations; Drug Compounding; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Logistic Models; Male; Middle Aged; Odds Ratio; Omeprazole; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Secondary Prevention; Stomach Ulcer; Tablets, Enteric-Coated; Time Factors; Treatment Outcome; Young Adult | 2016 |
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Topics: Aged; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Hemorrhage; Humans; Intestinal Obstruction; Intestinal Perforation; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Omeprazole; Pain; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Stroke; Ticlopidine | 2016 |
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome | 2016 |
Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aspirin; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Risk Factors | 2021 |
101 other study(ies) available for omeprazole and aspirin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Ulcer prevention in therapy with low-dose acetylsalicylic acid?].
Topics: Aspirin; Brain Ischemia; Coronary Disease; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer | 1991 |
Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Dog Diseases; Dogs; Double-Blind Method; Gastritis; Gastroscopy; Male; Omeprazole; Random Allocation; Stomach Ulcer | 1991 |
Different effects of cytoprotective drugs on ethanol- and aspirin-induced gastric mucosal injury in pylorus-ligated rats.
Topics: 16,16-Dimethylprostaglandin E2; 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Aspirin; Benzimidazoles; Cysteamine; Ethanol; Gastric Mucosa; Gastrointestinal Motility; Ligation; Omeprazole; Prostaglandins E, Synthetic; Pylorus; Rats | 1990 |
Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcholine; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Duodenum; Gastric Mucosa; Guinea Pigs; H(+)-K(+)-Exchanging ATPase; Heart Rate; Histamine; Ileum; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Omeprazole; Peptic Ulcer; Rabbits; Rats; Stress, Physiological | 1986 |
Indomethacin-induced gastric antral ulcers in hamsters.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Cricetinae; Dinoprostone; Disease Models, Animal; Gastric Acid; Indomethacin; Injections, Subcutaneous; Male; Mesocricetus; Omeprazole; Peptic Ulcer Perforation; Prostaglandins E; Stomach Ulcer; Time Factors | 1988 |
Effect of cimetidine and omeprazole on aspirin and taurocholate-induced gastric mucosal damage.
Topics: Animals; Aspirin; Benzimidazoles; Cimetidine; Gastric Mucosa; Omeprazole; Rats; Taurocholic Acid | 1986 |
Effect of cimetidine and omeprazole on aspirin- and taurocholate-induced gastric mucosal damage in the rat.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Cimetidine; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Omeprazole; Rats; Rats, Inbred Strains; Taurocholic Acid | 1985 |
Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats.
Topics: Animals; Aspirin; Benzimidazoles; Dose-Response Relationship, Drug; Epoprostenol; Ethanol; Female; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Prostaglandins; Rats; Rats, Inbred Strains; Stomach Ulcer | 1983 |
Omeprazole provides protection against experimentally induced gastric mucosal lesions.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Ethanol; Female; Injections, Intravenous; Omeprazole; Rats; Rats, Inbred Strains; Stomach Ulcer; Time Factors | 1983 |
Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats.
Topics: Animals; Aspirin; Benzimidazoles; Chemical Phenomena; Chemistry; Duodenal Ulcer; Epirizole; Gastric Juice; Indomethacin; Male; Omeprazole; Prednisolone; Rats; Rats, Inbred Strains; Stomach Ulcer | 1984 |
Cytoprotective effect of NC-1300-O-3 against gastric lesions induced by necrotizing agents in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Capillary Permeability; Dose-Response Relationship, Drug; Ethanol; Gastric Mucosa; Glutathione; Hexosamines; Male; Membrane Potentials; Omeprazole; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1994 |
Comparative evaluation of ulcer prevention efficacy of orally, rectally and sublingually administered omeprazole in three acute gastric ulcer models in rats.
Topics: Administration, Oral; Administration, Rectal; Administration, Sublingual; Animals; Aspirin; Female; Hydrochloric Acid; Indomethacin; Ligation; Male; Models, Biological; Omeprazole; Peptic Ulcer; Rats; Rats, Wistar | 1993 |
Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats.
Topics: 1,2-Dipalmitoylphosphatidylcholine; 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biological Availability; Drug Carriers; Enzyme Inhibitors; Gastric Mucosa; Male; Neutralization Tests; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley | 1997 |
Gastric mucosal function following withdrawal of omeprazole in rats.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Ulcer Agents; Aspirin; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1998 |
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastric Acid; Gastric Mucosa; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Male; Omeprazole; Pentagastrin; Perfusion; Pyrilamine; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1998 |
Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Drug Interactions; Gastric Acid; Lansoprazole; Male; Nizatidine; Omeprazole; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Sucralfate | 1998 |
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biological Availability; Enzyme Inhibitors; Gastrointestinal Diseases; Humans; Omeprazole; Proton Pump Inhibitors | 1999 |
Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Diabetes Mellitus, Experimental; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Nitric Oxide Donors; Nitro Compounds; Omeprazole; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Salicylic Acid; Stomach Diseases; Stomach Ulcer | 2000 |
Protective effects of prostaglandins in the isolated gastric mucosa of the eel, Anguilla anguilla.
Topics: Alkalies; Anguilla; Animals; Aspirin; Bicarbonates; Buffers; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; HEPES; Histamine; Indomethacin; Omeprazole; Sodium | 2000 |
Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cysteamine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Indomethacin; Omeprazole; Perfusion; Proton Pump Inhibitors; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley; Sodium Hydroxide; Stomach; Stomach Ulcer; Time Factors | 2001 |
Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine | 2001 |
Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Aspirin; Disease Models, Animal; Drug Evaluation, Preclinical; Famotidine; Female; Free Radical Scavengers; Gastric Acidity Determination; Lipid Peroxidation; Male; Melatonin; Omeprazole; Rats; Stomach Ulcer | 2001 |
Preventing upper gastrointestinal bleeding in patients with Helicobacter pylori infection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Secondary Prevention | 2001 |
[Long-term prophylaxis with omeprazol is superior to eradication therapy in H. pylori-positive NSAIDs taking patients].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Naproxen; Omeprazole; Peptic Ulcer Hemorrhage; Randomized Controlled Trials as Topic; Recurrence; Risk Factors | 2002 |
Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Furans; Male; Naphthalenes; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 2002 |
Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice.
Topics: Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Brazil; Cimetidine; Cucurbitaceae; Ethanol; Female; Flavonoids; Gastric Mucosa; Indomethacin; Male; Mice; Morphine; Motor Activity; Omeprazole; Phytotherapy; Plant Extracts; Rats; Stomach Ulcer; Tail; Toxicity Tests, Acute | 2002 |
Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Ethanol; Hydrochloric Acid; Lansoprazole; Ligation; Male; Mice; Molecular Structure; Oleanolic Acid; Omeprazole; Phytotherapy; Pylorus; Ranitidine; Rats; Rats, Sprague-Dawley; Solanaceae; Stomach Ulcer; Toxicity Tests, Acute | 2002 |
Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biological Availability; Humans; Misoprostol; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stomach Ulcer | 2002 |
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention | 2002 |
Low-dose aspirin: protection from the panacea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Secondary Prevention; Ulcer | 2002 |
[A case for proton pump blocker... When cough comes from the stomach].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Aspirin; Chronic Disease; Cough; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Time Factors | 2002 |
An aspirin a day keeps the cardiologist away (but what about the gastroenterologist?).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Gastrointestinal Diseases; Heart Diseases; Humans; Lansoprazole; Omeprazole; Secondary Prevention; Ulcer | 2003 |
Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Risk Factors; Time Factors | 2003 |
[Heartburn without esophagitis. Symptoms more important than the finding?].
Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Aspirin; Barrett Esophagus; Child; Cross-Over Studies; Cyclooxygenase Inhibitors; Deglutition Disorders; Diagnosis, Differential; Double-Blind Method; Dyspepsia; Endoscopy; Eosinophilia; Esophagitis; Esophagitis, Peptic; Family Practice; Fluticasone; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Middle Aged; Omeprazole; Prednisone; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Surveys and Questionnaires; Time Factors | 2003 |
Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.
Topics: Adenocarcinoma; Adult; Aged; Anti-Ulcer Agents; Aspirin; Barrett Esophagus; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Esophageal Neoplasms; Evidence-Based Medicine; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; United Kingdom | 2004 |
COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Humans; Isoenzymes; Membrane Proteins; Omeprazole; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Sulfonamides | 2004 |
Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2005 |
Allophylus serratus: a plant with potential anti-ulcerogenic activity.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Aspirin; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Female; Gastric Mucosa; Male; Mucus; Omeprazole; Phytotherapy; Plant Extracts; Plant Leaves; Rats; Rats, Sprague-Dawley; Sapindaceae; Solvents; Stomach Ulcer | 2005 |
Desmodium gangeticum: a potent anti-ulcer agent.
Topics: Alcohols; Animals; Anti-Ulcer Agents; Aspirin; Cold Temperature; Duodenal Ulcer; Ethanol; Fabaceae; Female; Guinea Pigs; Histamine; Male; Omeprazole; Peptic Ulcer; Pilot Projects; Plant Extracts; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sucralfate | 2005 |
Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Female; Humans; Lansoprazole; Methotrexate; Omeprazole; Pancytopenia | 2006 |
[Gastric protection and treatment with low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cohort Studies; Controlled Clinical Trials as Topic; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Meta-Analysis as Topic; Odds Ratio; Omeprazole; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk; Risk Factors; Stomach; Stomach Ulcer; Tablets, Enteric-Coated; Time Factors | 2006 |
Drug injury in the upper gastrointestinal tract: nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Gastrointestinal Tract; Humans; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2006 |
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin.
Topics: Aged; Angioplasty; Aryl Hydrocarbon Hydroxylases; Aspirin; Cell Adhesion Molecules; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Drug Antagonism; Enzyme Inhibitors; Female; Humans; Male; Microfilament Proteins; Mixed Function Oxygenases; Omeprazole; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Protein Processing, Post-Translational; Thrombosis; Ticlopidine | 2006 |
Anti-ulcer activity of crude alcoholic extract of Toona ciliata Roemer (heart wood).
Topics: Animals; Anti-Ulcer Agents; Aspirin; Disease Models, Animal; Ethanol; Female; Ligation; Male; Medicine, Traditional; Meliaceae; Omeprazole; Phytotherapy; Plant Bark; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological; Sucralfate | 2007 |
[Platelet inhibition and gastric problems].
Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Ticlopidine | 2007 |
Intracranial hypotension following motor vehicle accident: an overlooked cause of post-traumatic head and neck pain?
Topics: Accidents, Traffic; Analgesics; Aspirin; Blood Patch, Epidural; Diplopia; Drug Therapy, Combination; Female; Headache; Humans; Ibuprofen; Intracranial Hypotension; Middle Aged; Neck Pain; Omeprazole | 2007 |
Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats.
Topics: Alkaloids; Ammonia; Animals; Armoracia; Aspirin; Benzodioxoles; Capsaicin; Dose-Response Relationship, Drug; Ethanol; Food Preservatives; Gastric Mucosa; Hydrochloric Acid; Indomethacin; Isothiocyanates; Male; NG-Nitroarginine Methyl Ester; Omeprazole; Piperidines; Polyunsaturated Alkamides; Prostaglandins; Rats; Rats, Sprague-Dawley; Ruthenium Red; Structure-Activity Relationship | 2007 |
Letter to the editor, re: Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum O, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patient
Topics: Angioplasty, Balloon; Aspirin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Intermittent Claudication; Omeprazole; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
[Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2007 |
Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiology; Coronary Care Units; Female; Gastroenterology; Humans; Inservice Training; Internship and Residency; Male; Medical Order Entry Systems; Medical Records Systems, Computerized; Middle Aged; Misoprostol; Omeprazole; Patient Discharge; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Risk Factors; Software; Telemetry | 2008 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Humans; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Stents; Ticlopidine | 2009 |
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Stents; Ticlopidine | 2009 |
Aspirin in the primary prevention of vascular disease.
Topics: Anti-Ulcer Agents; Aspirin; Barrett Esophagus; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Omeprazole; Patient Selection; Platelet Aggregation Inhibitors; Primary Prevention; Vascular Diseases | 2009 |
[Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Incidence; Ketoprofen; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Factors | 2010 |
Interactive medical case. Bitter pills.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy; Creatinine; Fatigue; Glucocorticoids; Histamine H2 Antagonists; Humans; Kidney; Male; Methylprednisolone; Middle Aged; Nephritis, Interstitial; Omeprazole; Peptic Ulcer Hemorrhage; Stomach Ulcer; Ultrasonography; Urinalysis | 2010 |
Clinical problem-solving. Bitter pills.
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Diagnosis, Differential; Fatigue; Glucocorticoids; Humans; Kidney; Male; Middle Aged; Nephritis, Interstitial; Omeprazole; Peptic Ulcer Hemorrhage; Stomach Ulcer; Urinalysis; Urination Disorders | 2010 |
"War and Peace" with Barrett's esophagus.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Barrett Esophagus; Celecoxib; Drug Therapy, Combination; Endoscopy; Esophageal Neoplasms; Fundoplication; Gastroesophageal Reflux; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Omeprazole; Pyrazoles; Quality of Life; Sulfonamides; Treatment Outcome | 2011 |
Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?
Topics: Aspirin; Cardiovascular Diseases; Endoscopy, Gastrointestinal; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Primary Prevention; Proton Pump Inhibitors; Risk; Risk Factors | 2011 |
Double-dose clopidogrel in patients undergoing PCI for ACS.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2011 |
Anti-ulcer constituents of Annona squamosa twigs.
Topics: Animals; Annona; Anti-Ulcer Agents; Aporphines; Aspirin; Benzylisoquinolines; Berberine Alkaloids; Cold Temperature; Dinoprostone; Disaccharides; Drug Evaluation, Preclinical; Duodenal Ulcer; Ethanol; Gastric Juice; Gastrins; Guinea Pigs; H(+)-K(+)-Exchanging ATPase; Histamine; Ligation; Omeprazole; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Physiological | 2011 |
Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Databases, Factual; Drug Interactions; Esomeprazole; Female; Herb-Drug Interactions; Hospitalization; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Ticlopidine; Treatment Outcome | 2011 |
Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Arbutin; Aspirin; Cell Line; Cytoprotection; Disease Models, Animal; Ethanol; Female; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Immunologic Factors; Interleukin-10; Interleukin-6; Lipid Peroxidation; Liver; Male; Mucus; Nitric Oxide; Omeprazole; Phytotherapy; Plant Extracts; Plants, Medicinal; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Turnera | 2012 |
A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Interactions; Famotidine; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Omeprazole; Peroxidase; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Ticlopidine | 2012 |
Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Asian People; Aspirin; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Drug Therapy, Combination; Enzyme Inhibitors; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ticlopidine | 2012 |
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Hypertension; Male; Naproxen; Nitrates; Obesity; Omeprazole; Pyrazoles; Rats; Rats, Inbred SHR; Rats, Wistar; Rats, Zucker; Sulfonamides | 2012 |
I've taken aspirin for years to prevent heart attack, and now I've developed an ulcer. My doctor told me to keep taking aspirin along with Prilosec. Why keep taking aspirin if it caused my ulcer?
Topics: Anti-Ulcer Agents; Aspirin; Humans; Myocardial Infarction; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors | 2012 |
Antiulcerogenic activity of hydroalcoholic fruit extract of Pithecellobium dulce in different experimental ulcer models in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Carbohydrate Metabolism; Cell Proliferation; Cold Temperature; Dinoprostone; Disease Models, Animal; Ethanol; Fabaceae; Fruit; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Male; Mucins; Omeprazole; Peroxidase; Phytotherapy; Plant Extracts; Proteins; Rats; Rats, Wistar; Severity of Illness Index; Stomach Ulcer | 2012 |
Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2; Indoles; Male; Omeprazole; Rats; Stomach; Stomach Ulcer | 2014 |
Is 325 mg of prevention worth a pound of cure?
Topics: Aspirin; Barrett Esophagus; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; Male; Omeprazole; Proton Pump Inhibitors | 2012 |
Proton-pump inhibitors could be innocent when used concomitantly with clopidogrel.
Topics: Acute Coronary Syndrome; Anti-Ulcer Agents; Aspirin; Blood Platelets; Clopidogrel; Famotidine; Female; Humans; Male; Omeprazole; Platelet Aggregation Inhibitors; Ticlopidine | 2012 |
Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Disease Models, Animal; Ethanol; Female; Fruit; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Hydrolyzable Tannins; Inhibitory Concentration 50; Ligation; Male; Mucins; Omeprazole; Phytotherapy; Plant Extracts; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stomach; Stomach Ulcer; Sucralfate; Terminalia | 2013 |
Common medications among dental outpatients: considerations in general dental practice.
Topics: Acetaminophen; Adolescent; Adult; Age Distribution; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Cilazapril; Dental Clinics; Drug Interactions; Drug Utilization; Female; General Practice, Dental; Humans; Male; Middle Aged; New Zealand; Omeprazole; Outpatients; Polypharmacy; Retrospective Studies; Young Adult | 2012 |
Anti-secretory and cyto-protective effects of peganine hydrochloride isolated from the seeds of Peganum harmala on gastric ulcers.
Topics: Alcohols; Alkaloids; Animals; Anti-Ulcer Agents; Antioxidants; Aspirin; Cold Temperature; Disease Models, Animal; H(+)-K(+)-Exchanging ATPase; Male; Molecular Structure; Omeprazole; Peganum; Plant Extracts; Pylorus; Quinazolines; Rats; Rats, Sprague-Dawley; Seeds; Stomach Ulcer; Sucralfate | 2013 |
[HP eradication prevents recurrent hemorrhages caused by acetylsalicylic acid].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cohort Studies; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention | 2013 |
Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Thromboembolism | 2014 |
Histopathological evaluation of gastro protective effect of Berberis vulgaris (Zereshk) seeds against aspirin induced ulcer in albino mice.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Antioxidants; Aspirin; Berberis; Cell Proliferation; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Gastric Mucosa; Male; Mice; Omeprazole; Oxidative Stress; Phytotherapy; Plant Extracts; Plants, Medicinal; Powders; Proton Pump Inhibitors; Seeds; Stomach Ulcer | 2015 |
A COGENT Argument for Gastrointestinal Protection With Low-Dose Aspirin.
Topics: Aspirin; Female; Humans; Male; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2016 |
The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.
Topics: Adult; Aged; Aspirin; Budgets; Cardiovascular Diseases; Clopidogrel; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Male; Markov Chains; Medication Adherence; Middle Aged; Models, Econometric; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine | 2017 |
Combination cardiovascular drugs.
Topics: Aminobutyrates; Amlodipine; Aspirin; Biphenyl Compounds; Cardiovascular Agents; Cardiovascular Diseases; Drug Combinations; Humans; Nebivolol; Omeprazole; Perindopril; Tetrazoles; Valsartan | 2017 |
Stability Indicating Liquid Chromatographic Method for Simultaneous Determination of Aspirin and Omeprazole.
Topics: Aspirin; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Drug Compounding; Drug Stability; Feasibility Studies; Fibrinolytic Agents; Humans; Omeprazole; Quality Control; Stomach Ulcer; Thrombosis | 2018 |
Small bowel obstruction secondary to enteroenteric fistula: An uncommon complication in chronic NSAID users.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Female; Humans; Ileal Diseases; Intestinal Fistula; Intestinal Obstruction; Intestinal Perforation; Intestine, Small; Jejunal Diseases; Omeprazole; Tomography, X-Ray Computed | 2020 |
Green analysis of newly approved binary omeprazole/aspirin mixture in presence of aspirin impurity using ultra-high-performance liquid chromatography and thin-layer chromatography methods.
Topics: Aspirin; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Contamination; Green Chemistry Technology; Limit of Detection; Linear Models; Omeprazole; Reproducibility of Results; Salicylic Acid | 2021 |
Treatment effects of Shilajit on aspirin-induced gastric lesions in rats.
Topics: Animals; Antioxidants; Aspirin; Gastric Mucosa; Male; Minerals; Omeprazole; Oxidative Stress; Peptic Ulcer; Rats; Rats, Wistar; Resins, Plant | 2021 |
Application of different spectrofluorimetric approaches for quantitative determination of acetylsalicylic acid and omeprazole in recently approved pharmaceutical preparation and human plasma.
Topics: Aspirin; Calibration; Humans; Omeprazole; Spectrometry, Fluorescence; Tablets | 2021 |
Spectrophotometric Determination of Aspirin and Omeprazole in the Presence of Salicylic Acid as a Degradation Product: A Comparative Evaluation of Different Univariate/Multivariate Post Processing Algorithms.
Topics: Algorithms; Aspirin; Calibration; Humans; Least-Squares Analysis; Omeprazole; Salicylic Acid; Spectrophotometry | 2022 |
Earth friendly spectrophotometric methods based on different manipulation approaches for simultaneous determination of aspirin and omeprazole in binary mixture and pharmaceutical dosage form: Comparative statistical study.
Topics: Aspirin; Humans; Omeprazole; Pharmaceutical Preparations; Spectrophotometry | 2022 |
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2
Topics: Aged; Aged, 80 and over; Aspirin; Betamethasone; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Dietary Supplements; Early Diagnosis; Female; Flavonoids; Follow-Up Studies; Heparin, Low-Molecular-Weight; Hospitalization; Humans; Indomethacin; Italy; Male; Middle Aged; Omeprazole; Patient Acuity; Retrospective Studies; Risk Assessment; SARS-CoV-2; Time; Time-to-Treatment; Treatment Outcome | 2021 |
Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Omeprazole; Risk; Stomach Neoplasms | 2023 |